Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Medicina Intensiva|June 1, 2022
The role of the microbiology laboratory in the diagnosis of multidrug-resistant Gram-negative bacilli infections. The importance of the determination of resistance mechanismsI López-Hernández, L López-Cerero, F Fernández-Cuenca, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 12, 2011
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coliJ Rodríguez-Baño, E Picón, M D Navarro, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 15, 2011
Assessment of the presence of extended-spectrum beta-lactamase-producing Escherichia coli in eggshells and ready-to-eat productsP Egea, L López-Cerero, M D Navarro, et al.Epidemiology and Infection|February 4, 2016
Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centresA Talaminos, L López-Cerero, J Calvillo, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2017
Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patientsE Torres, L López-Cerero, I Morales, et al.Journal of Clinical Microbiology|February 22, 2008
Fatal levofloxacin failure in treatment of a bacteremic patient infected with Streptococcus pneumoniae with a preexisting parC mutationM de Cueto, J M Rodríguez, M J Soriano, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 21, 2009
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolatesL López-Cerero, E Picón, C Morillo, et al.The Journal of Hospital Infection|September 25, 2018
Vagino-rectal colonization and maternal-neonatal transmission of Enterobacteriaceae producing extended-spectrum β-lactamases or carbapenemases: a cross-sectional studyC Jiménez-Rámila, L López-Cerero, M V Aguilar Martín, et al.Antimicrobial Agents and Chemotherapy|February 27, 2013
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis modelF Docobo-Pérez, L López-Cerero, R López-Rojas, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2009
Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, SpainY Doi, D L Paterson, P Egea, et al.Pageof 2